{"mainPropery":{"diseaseId":10646,"diseaseName":"Teratoma with malignant transformation","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10646/teratoma-with-malignant-transformation","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"UMLS","identifierId":"C0039538"}]},"diseaseCategories":[{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[],"resource descriptions":[{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://clinicaltrials.gov/ct2/results?term=teratoma+AND+malignant&recr=Open' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Teratoma with malignant transformation. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/427395-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6418,"questionText":"What is a teratoma with malignant transformation?","answerText":"A <strong>teratoma with malignant transformation (TMT)</strong>&nbsp;is a <a href=\"http://www.cancer.gov/dictionary?CdrID=46634\" target=_blank>tumor</a> that develops from&nbsp;<a href=\"http://www.cancer.gov/dictionary?CdrID=46382\" target=_blank>germ cells</a>&nbsp;when they grow and divide abnormally, forming a <a href=\"http://www.cancer.gov/dictionary?CdrID=638197\" target=_blank>mass</a>.&nbsp;&nbsp;Approximately 6% of <a href=\"http://www.cancer.gov/dictionary?CdrID=44248\" target=_blank>teratomas</a> develop into TMTs by a process called&nbsp;<a href=\"http://www.cancer.gov/dictionary?CdrID=45772\" target=_blank>malignant</a> <a href=\"http://www.cancer.gov/dictionary?CdrID=46628\" target=_blank>transformation</a>, when some of the cells in the teratoma become cancerous.&nbsp;&nbsp;TMTs can occur anywhere in the body,&nbsp;but most are located in the testes in men or ovaries in women.&nbsp; The cause of TMT is unknown.&nbsp; Treatment may include surgery and <a href=\"http://www.cancer.gov/dictionary?CdrID=45214\" target=_blank>chemotherapy</a>.[5498]","dateModified":"2012-09-21T07:58:00"},"basicQuestions":[{"questionId":6419,"questionText":"What treatments are available for teratoma with malignant transformation?","answerText":"Because teratoma with malignant transformation (TMT) is quite rare, there are no established treatment guidelines.&nbsp; In general, treatment often&nbsp;includes&nbsp;surgery to remove as much of the TMT as possible.&nbsp; <a href=\"http://www.cancer.gov/dictionary?CdrID=45214\" target=_blank>Chemotherapy</a> that is specifically designed to target the malignant part of the TMT may also be used.[5497][5498]","dateModified":"2012-09-21T07:47:00","resourceClassificationName":"Treatment","references":[{"referenceId":5497,"authors":"Athanasiou A, Vanel D, El Mesbahi O, Theodore C, Fizazi K","articleTitle":"Non-germ cell tumours arising in germ cell tumours (teratoma with malignant transformation) in men: CT and MR findings","bookWebsiteJournalTitle":"European Journal of Radiology","date":"2009","volume":"69","pages":"230-235","url":"http://www.ncbi.nlm.nih.gov/pubmed/19056194","dateAccessed":"2012-09-20T00:00:00"},{"referenceId":5498,"authors":"El Mesbahi O, Terrier-Lacombe MJ, Rebischung C, Theodore C, Vanel D, Fizazi K","articleTitle":"Chemotherapy in patients with teratoma with malignant transformation","bookWebsiteJournalTitle":"European Urology","date":"2007","volume":"51","pages":"1306-1311","url":"http://www.ncbi.nlm.nih.gov/pubmed/17081678","dateAccessed":"2012-09-20T00:00:00"}]},{"questionId":6420,"questionText":"What is the prognosis for teratoma with malignant transformation?","answerText":"<a href=\"http://www.cancer.gov/dictionary?CdrID=45849\" target=_blank>Prognosis</a> depends on the extent of disease and effectiveness of surgery; it is best when teratomas with malignant transformation (TMTs) have not spread to other parts of the body (<a href=\"http://www.cancer.gov/dictionary?CdrID=46283\" target=_blank>metastasized</a>) and when surgery successfully removes all of the tumor cells.[5497][5499]&nbsp; One article states that up to 60% of individuals diagnosed with teratoma with malignant transformation are alive five years after diagnosis.&nbsp; The authors of this article also state that it is not known if the particular type of the <a href=\"http://www.cancer.gov/dictionary?CdrID=45772\" target=_blank>malignant</a> component changes prognosis.[5497]","dateModified":"2012-09-21T07:45:00","resourceClassificationName":"Prognosis","references":[{"referenceId":5497,"authors":"Athanasiou A, Vanel D, El Mesbahi O, Theodore C, Fizazi K","articleTitle":"Non-germ cell tumours arising in germ cell tumours (teratoma with malignant transformation) in men: CT and MR findings","bookWebsiteJournalTitle":"European Journal of Radiology","date":"2009","volume":"69","pages":"230-235","url":"http://www.ncbi.nlm.nih.gov/pubmed/19056194","dateAccessed":"2012-09-20T00:00:00"},{"referenceId":5499,"authors":"Motzer RJ, Amsterdam A, Prieto V, Sheinfeld J, Murty VV, Mazumdar M, Bosl GJ, Chaganti RS, Reuter VE","articleTitle":"Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors","bookWebsiteJournalTitle":"Journal of Urology","date":"1998","volume":"159","pages":"133-138","url":"http://www.ncbi.nlm.nih.gov/pubmed/9400455","dateAccessed":"2012-09-20T00:00:00"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":36693,"abbreviatedInquiry":"Is someone diagnosed with teratoma with malignant transformation (TMT) considered to have cancer?&nbsp; If so, is it the type of cancer within the teratoma or is TMT a cancerous classification?","caseQuestions":[{"questionId":6439,"questionText":"Is someone diagnosed with teratoma with malignant transformation (TMT) considered to have cancer?","answerText":"Yes.&nbsp;&nbsp;An individual with teratoma with malignant transformation (TMT) is considered to have cancer because some of the <a href=\"http://ghr.nlm.nih.gov/glossary=cell\" target=_blank>cells</a> in&nbsp;the teratoma have become <a href=\"http://www.cancer.gov/dictionary?CdrID=45772\" target=_blank>malignant</a>.&nbsp; A group of malignant cells is called a cancer.","dateModified":"2012-09-28T10:29:00","references":[]},{"questionId":6440,"questionText":"How is a teratoma with malignant transformation classified?","answerText":"Teratoma with malignant transformation (TMT) is classified as a specific type of cancer.[5517]&nbsp; TMT is the main classification group; TMTs in this group can be described further by the specific type of cancer cells within the TMT.","dateModified":"2012-09-28T10:35:00","references":[{"referenceId":5517,"authors":"National Cancer Institute","articleTitle":"ICD-O-2 to ICD-O-3: Neoplasms","bookWebsiteJournalTitle":"Surveillance, Epidemiology and End Results Program","date":"2000","url":"http://seer.cancer.gov/tools/conversion/ICDO2-3manual.pdf","dateAccessed":"2012-09-27T00:00:00"}]}]},{"caseId":36511,"abbreviatedInquiry":"I am trying to find out more information about teratomas with malignant transformation, specifically related to prognosis.&nbsp; I had a single mass removed with clean margins and no infiltration.&nbsp; Any studies that have been done about treatment options would be helpful.&nbsp;&nbsp;Also, are there any other published cases of teratoma and astrocytoma?&nbsp; I guess I am trying to find out if my type of teratoma would portend a better or worse prognosis than other types, especially given how fast mine developed.","caseQuestions":[{"questionId":6419,"questionText":"What treatments are available for teratoma with malignant transformation?","answerText":"Because teratoma with malignant transformation (TMT) is quite rare, there are no established treatment guidelines.&nbsp; In general, treatment often&nbsp;includes&nbsp;surgery to remove as much of the TMT as possible.&nbsp; <a href=\"http://www.cancer.gov/dictionary?CdrID=45214\" target=_blank>Chemotherapy</a> that is specifically designed to target the malignant part of the TMT may also be used.[5497][5498]","dateModified":"2012-09-21T07:47:00","resourceClassificationName":"Treatment","references":[{"referenceId":5497,"authors":"Athanasiou A, Vanel D, El Mesbahi O, Theodore C, Fizazi K","articleTitle":"Non-germ cell tumours arising in germ cell tumours (teratoma with malignant transformation) in men: CT and MR findings","bookWebsiteJournalTitle":"European Journal of Radiology","date":"2009","volume":"69","pages":"230-235","url":"http://www.ncbi.nlm.nih.gov/pubmed/19056194","dateAccessed":"2012-09-20T00:00:00"},{"referenceId":5498,"authors":"El Mesbahi O, Terrier-Lacombe MJ, Rebischung C, Theodore C, Vanel D, Fizazi K","articleTitle":"Chemotherapy in patients with teratoma with malignant transformation","bookWebsiteJournalTitle":"European Urology","date":"2007","volume":"51","pages":"1306-1311","url":"http://www.ncbi.nlm.nih.gov/pubmed/17081678","dateAccessed":"2012-09-20T00:00:00"}]},{"questionId":6420,"questionText":"What is the prognosis for teratoma with malignant transformation?","answerText":"<a href=\"http://www.cancer.gov/dictionary?CdrID=45849\" target=_blank>Prognosis</a> depends on the extent of disease and effectiveness of surgery; it is best when teratomas with malignant transformation (TMTs) have not spread to other parts of the body (<a href=\"http://www.cancer.gov/dictionary?CdrID=46283\" target=_blank>metastasized</a>) and when surgery successfully removes all of the tumor cells.[5497][5499]&nbsp; One article states that up to 60% of individuals diagnosed with teratoma with malignant transformation are alive five years after diagnosis.&nbsp; The authors of this article also state that it is not known if the particular type of the <a href=\"http://www.cancer.gov/dictionary?CdrID=45772\" target=_blank>malignant</a> component changes prognosis.[5497]","dateModified":"2012-09-21T07:45:00","resourceClassificationName":"Prognosis","references":[{"referenceId":5497,"authors":"Athanasiou A, Vanel D, El Mesbahi O, Theodore C, Fizazi K","articleTitle":"Non-germ cell tumours arising in germ cell tumours (teratoma with malignant transformation) in men: CT and MR findings","bookWebsiteJournalTitle":"European Journal of Radiology","date":"2009","volume":"69","pages":"230-235","url":"http://www.ncbi.nlm.nih.gov/pubmed/19056194","dateAccessed":"2012-09-20T00:00:00"},{"referenceId":5499,"authors":"Motzer RJ, Amsterdam A, Prieto V, Sheinfeld J, Murty VV, Mazumdar M, Bosl GJ, Chaganti RS, Reuter VE","articleTitle":"Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors","bookWebsiteJournalTitle":"Journal of Urology","date":"1998","volume":"159","pages":"133-138","url":"http://www.ncbi.nlm.nih.gov/pubmed/9400455","dateAccessed":"2012-09-20T00:00:00"}]},{"questionId":6417,"questionText":"Are there other published cases of teratoma with malignant transformation to astrocytoma?","answerText":"There are three other published cases of teratoma with malignant transformation to <a href=\"http://www.cancer.gov/dictionary?CdrID=45602\" target=_blank>astrocytoma</a>: one man was found to have a&nbsp;testicular teratoma including an astrocytoma component&nbsp;and two girls were found to have ovarian teratomas including an astrocytoma component.[5495][5496]","dateModified":"2012-09-21T07:49:00","references":[{"referenceId":5495,"authors":"Spiess PE, Pisters LL, Liu P, Pettaway CA, Kamat AM, Gomez JA, Tannir NM","articleTitle":"Malignant transformation of testicular teratoma: a chemoresistant phenotype","bookWebsiteJournalTitle":"Urologic Oncology","date":"2008","volume":"26","pages":"595-599","url":"http://www.ncbi.nlm.nih.gov/pubmed/18367105","dateAccessed":"2012-09-20T00:00:00"},{"referenceId":5496,"authors":"Biskup W, Calaminus G, Schneider DT, Leuschner I, Göbel U","articleTitle":"Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96","bookWebsiteJournalTitle":"Klinische Padiatrie","date":"2006","volume":"218","pages":"303-308","url":"http://www.ncbi.nlm.nih.gov/pubmed/17080331","dateAccessed":"2012-09-20T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Teratoma_with_malignant_transformation"}